Our science and technology are rooted in our deep and extensive knowledge of neuroscience and proteome informatics. By combining these with our computational strategies, we have developed two innovative platform technologies that enable us to design therapeutic interventions by manipulating how proteins interact and are degraded in ways that are not amenable using small molecules and antibodies.
Through our novel discovery programs, we identify key domains of disease related proteins, and design lead compounds that offer new therapeutic approaches by:
- blocking the interactions of two disease related proteins
- degrading the specific disease related proteins in the body